LifeMD, Inc.
General ticker "LFMD" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $278.0M (TTM average)
LifeMD, Inc. does not follow the US Stock Market performance with the rate: -13.8%.
Estimated limits based on current volatility of 2.7%: low 4.26$, high 4.49$
Factors to consider:
- Total employees count: 389 (+15.8%) as of 2025
- Top business risk factors: Market acceptance, Market competition, Regulatory and compliance, Limited operating history, Liquidity and credit risks
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.95$, 5.09$]
- 2026-12-31 to 2027-12-31 estimated range: [1.91$, 4.80$]
Financial Metrics affecting the LFMD estimates:
- Positive: with PPE of -19.4 at the end of fiscal year the price was neutral
- Positive: Inventory ratio change, % of 0.11 <= 0.80
- Positive: -5.34 < Operating profit margin, % of -3.80
- Positive: -0.03 < Operating cash flow per share per price, % of 5.36
- Positive: Investing cash flow per share per price, % of 4.47 > -0.60
- Positive: 19.19 < Shareholder equity ratio, % of 32.89 <= 42.57
- Negative: negative Net income
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 0.76
- Positive: Industry inventory ratio change (median), % of -1.30 <= -0.15
Short-term LFMD quotes
Long-term LFMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $152.55MM | $212.45MM | $194.06MM |
| Operating Expenses | $167.04MM | $228.60MM | $201.72MM |
| Operating Income | $-14.49MM | $-16.14MM | $-7.67MM |
| Non-Operating Income | $-2.92MM | $-2.18MM | $-2.52MM |
| Interest Expense | $2.60MM | $2.18MM | $1.36MM |
| R&D Expense | $6.06MM | $6.86MM | $7.35MM |
| Income(Loss) | $-17.41MM | $-18.33MM | $-10.19MM |
| Taxes | $0.43MM | $0.40MM | $0.05MM |
| Other Income(Loss) | $0.00MM | $2.32MM | $25.85MM |
| Net Income(Loss)* | $-20.60MM | $-18.88MM | $14.35MM |
| Stockholders Equity | $3.51MM | $-5.49MM | $23.16MM |
| Inventory | $2.76MM | $2.80MM | $2.77MM |
| Assets | $58.48MM | $72.46MM | $70.41MM |
| Operating Cash Flow | $8.82MM | $17.51MM | $8.28MM |
| Capital expenditure | $8.73MM | $11.54MM | $9.52MM |
| Investing Cash Flow | $-8.73MM | $-11.54MM | $6.91MM |
| Financing Cash Flow | $29.10MM | $-4.12MM | $-13.41MM |
| Earnings Per Share** | $-0.61 | $-0.46 | $0.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.